These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2864302)

  • 1. A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals.
    Del Soldato P; Campieri M; Brignola C; Bazzocchi G; Gionchetti P; Lanfranchi GA; Tamba M
    Gastroenterology; 1985 Nov; 89(5):1215-6. PubMed ID: 2864302
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory bowel disease and male infertility: effects of sulfasalazine and 5-aminosalicylic acid on sperm-fertilizing capacity and reactive oxygen species generation.
    Wu FC; Aitken RJ; Ferguson A
    Fertil Steril; 1989 Nov; 52(5):842-5. PubMed ID: 2572460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salazosulfapyridine or 5-aminosalicylic acid].
    Terpstra JJ
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1409-10. PubMed ID: 2889151
    [No Abstract]   [Full Text] [Related]  

  • 4. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Craven PA; Pfanstiel J; Saito R; DeRubertis FR
    Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.
    Chan RP; Pope DJ; Gilbert AP; Sacra PJ; Baron JH; Lennard-Jones JE
    Dig Dis Sci; 1983 Jul; 28(7):609-15. PubMed ID: 6345112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ).
    Gionchetti P; Guarnieri C; Campieri M; Belluzzi A; Brignola C; Iannone P; Miglioli M; Barbara L
    Gut; 1990 Jun; 31(6):730-1. PubMed ID: 1974235
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the intestinal flora in the acetylation of sulfasalazine metabolites.
    Dull BJ; Salata K; Goldman P
    Biochem Pharmacol; 1987 Nov; 36(21):3772-4. PubMed ID: 2890356
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfasalazine and 5-ASA compounds.
    Allgayer H
    Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine and its anti-inflammatory metabolite, 5-aminosalicylic acid: effect on arachidonic acid metabolism in human neutrophils, and free radical scavenging.
    Ahnfelt-Rønne I; Nielsen OH; Bukhave K; Elmgreen J
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():918-22. PubMed ID: 2890286
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid.
    Ahnfelt-Rønne I; Nielsen OH; Christensen A; Langholz E; Binder V; Riis P
    Gastroenterology; 1990 May; 98(5 Pt 1):1162-9. PubMed ID: 1969825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats.
    Pieniaszek HJ; Bates TR
    J Pharm Sci; 1979 Oct; 68(10):1323-5. PubMed ID: 41931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.
    Bondesen S; Tage-Jensen U; Jacobsen O; Hansen SH; Rasmussen SN; Hvidberg EF
    Eur J Clin Pharmacol; 1986; 31(1):23-6. PubMed ID: 2877884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U
    Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and azo-link cleavage of salazopyrine in man.
    Lewkonia RM; Schröder H; Evans DA
    Gut; 1973 May; 14(5):426-7. PubMed ID: 4146086
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphasalazine: drug or pro-drug?
    Lancet; 1987 Jun; 1(8545):1299-301. PubMed ID: 2884417
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.
    Azad Khan AK; Nurazzaman M; Truelove SC
    J Med Genet; 1983 Feb; 20(1):30-6. PubMed ID: 6133000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl.
    Nielsen OH; Ahnfelt-Rønne I
    Pharmacol Toxicol; 1988 Apr; 62(4):223-6. PubMed ID: 3133649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity.
    Joshi R; Kumar S; Unnikrishnan M; Mukherjee T
    Free Radic Res; 2005 Nov; 39(11):1163-72. PubMed ID: 16298742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.